Anbio Biotechnology ("Anbio"), a global leader in in-vitro diagnostic technologies, is excited to announce its participation ...
About Anbio Biotechnology Anbio Biotechnology is a leading global medical device company specializing in in vitro diagnostics. Its diverse portfolio spans multiple medical fields, including cancer ...
Anbio Biotechnology (NNNN) has filed to raise $8.8 million in an IPO of its Class A ordinary shares, according to an SEC F-1 registration statement. NNNN provides in vitro diagnostics products for ...
Anbio Biotechnology filed for a 1.6 million-share initial public offering with the Securities and Exchange Commission. The company said Tuesday it expects the IPO to price between $5 and $6 per ...
Hosted on MSN20d
Medtech test developer Anbio files for $9M US IPOAnbio Biotechnology (NNNN), a developer of in vitro diagnostics, has filed to raise around $9M through a U.S. initial public offering. The medtech company said in an SEC filing that it was looking ...
Eliminates the need for cold chain logistics, enabling room temperature storage and operation. Reagents remain stable without refrigeration, reducing costs and logistical challenges. Advanced ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback